{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T05:08:57Z","timestamp":1694927337188},"reference-count":18,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ejim.2013.02.001","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:43:58Z","timestamp":1363394638000},"page":"285-287","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Thromboprophylaxis in the oldest old with atrial fibrillation: Between Scylla and Charybdis"],"prefix":"10.1016","volume":"24","author":[{"given":"Pier Mannuccio","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.02.001_bb0005","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.02.001_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2013.02.001_bb0015","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1161\/STROKEAHA.109.558759","article-title":"Age disparities in stroke quality of care and delivery of health services","volume":"40","author":"Saposnik","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2013.02.001_bb0020","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.02.001_bb0025","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.110.007864","article-title":"Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation","volume":"124","author":"Poli","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.02.001_bb0030","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejim.2010.07.014","article-title":"Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards","volume":"21","author":"Marcucci","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2013.02.001_bb0035","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/STROKEAHA.108.526988","article-title":"Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators","volume":"40","author":"van Walraven","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2013.02.001_bb0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.02.001_bb0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.02.001_bb0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.02.001_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2011.11.007","article-title":"New drugs for thromboprophylaxis in atrial fibrillation","volume":"23","author":"Mannucci","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2013.02.001_bb0060","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1538-7836.2012.04866.x","article-title":"Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results","volume":"10","author":"Pengo","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.02.001_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2796.2011.02464.x","article-title":"Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation","volume":"271","author":"Sinnaeve","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2013.02.001_bb0070","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.110.004747","article-title":"Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial","volume":"123","author":"Eikelboom","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.02.001_bb0075","first-page":"A15537","article-title":"Dabigatran versus warfarin in very elderly patients with atrial fibrillation: results from the RE-LY trial","volume":"126","author":"Coppens","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.02.001_bb0080","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60986-6","article-title":"Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomized controlled trial","volume":"380","author":"Lopes","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.02.001_bb0085","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1160\/TH11-10-0721","article-title":"Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)","volume":"107","author":"Poli","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.02.001_bb0090","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T01:31:10Z","timestamp":1539826270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0953620513000447"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.02.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboprophylaxis in the oldest old with atrial fibrillation: Between Scylla and Charybdis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}